Brief: Hookipa Pharma Achieves $5 Mln Milestone Payment From Gilead Sciences

Hookipa Pharma

04/01/2023 12:43

Jan 4 (Reuters) - HOOKIPA Pharma Inc  HOOK.O :
    * HOOKIPA PHARMA ACHIEVES $5 MILLION MILESTONE PAYMENT FROM
GILEAD
SCIENCES FOR PROGRESS IN THE DEVELOPMENT OF HEPATITIS B VACCINE
    * HOOKIPA PHARMA INC - FIRST PARTICIPANT IN PHASE 1 CLINICAL
TRIAL
IS EXPECTED TO BE DOSED IN 2023
    * HOOKIPA PHARMA INC -  GILEAD IS SOLELY RESPONSIBLE FOR
FURTHER
DEVELOPMENT AND COMMERCIALIZATION OF HEPATITIS B PRODUCT
CANDIDATE
    * HOOKIPA- ELIGIBLE TO GET MILESTONE PAYMENTS BASED ON
ACHIEVEMENT
OF SPECIFIED DEVELOPMENT, COMMERCIAL MILESTONES UP TO TOTAL MORE
THAN $190 MILLION
    * HOOKIPA PHARMA INC - HOOKIPA IS ALSO ELIGIBLE TO RECEIVE
TIERED
ROYALTIES ON NET SALES

Source text for Eikon:  ID:nGNX2bHXpb 
Further company coverage:  HOOK.O 
 ((Reuters.Briefs@thomsonreuters.com;))